Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ASPH | Q12797 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 2/20 | 0.36 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FABP4 | P15090 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31440667 | 1.00 | DAO (0.41) | DAOALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL31440665 | 0.81 | CFTR (0.43) | ALDH1A1HPGDKDM4EHSD17B10CES2 | |
| SCHEMBL22462321 | 0.81 | CFTR (0.43) | ALDH1A1HPGDKDM4EHSD17B10CES2 | |
| SCHEMBL21585752 | 0.74 | DAO (0.37) | DAOALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL22749580 | 0.73 | ALDH1A1 (0.36) | DAOALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL22831405 | 0.70 | KMT2A (0.38) | DAOALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL22462326 | 0.69 | KDM4E (0.40) | DAOALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL9700677 | 0.68 | SELL (0.54) | DAOALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL4647359 | 0.68 | ALDH1A1 (0.43) | DAOALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL1458482 | 0.68 | KDM4E (0.43) | DAOALDH1A1HPGDKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116956-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-11 | — | — | US | disclosed |
| US-11897904-B2 | Herbicidally active bicyclic benzamides | BAYER AKTIENGESELLSCHAFT (DE) | 2024-02-13 | — | — | US | disclosed |
| EP-3713417-B1 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | BAYER AG (DE) | 2024-01-17 | — | — | EP | disclosed |
| US-20200325159-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-10-15 | — | — | US | disclosed |
| EP-3713417-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | Bayer Aktiengesellschaft (DE) | 2020-09-30 | — | — | EP | disclosed |
| CN-111356368-A | Herbicidally active bicyclic benzamides | 拜耳公司 | 2020-06-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11897904-B2 | Herbicidally active bicyclic benzamides | CBR3, CBR1, AOX1 | DAO 90/4885ALDH1A1 756/4885HPGD 1541/4885 |
| US-20200325159-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | CBR3, CBR1, AOX1 | DAO 90/4885ALDH1A1 756/4885HPGD 1541/4885 |
| US-20240116956-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | CBR3, CBR1, AOX1 | DAO 90/4885ALDH1A1 756/4885HPGD 1541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.